Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Satoh; Toshio
Address:
Tokushima, JP
No. of patents:
25
Patents:




Patent Number Title Of Patent Date Issued
RE36139 Hydroquinone derivative March 9, 1999
Novel hydroquinone derivatives of the formulae (I) and (II), ##STR1## wherein R.sup.1 is an alkyl group having 7 to 11 carbon atoms, ##STR2## wherein each of R.sup.2 to R.sup.5 is independently a hydrogen atom, a lower alkyl group or a lower alkoxy group provided that at least on
5910499 Antiallergic agent having an anti-oxidant action June 8, 1999
An antiallergic agent having leucotriene production inhibiting action and antihistaminic action, which can be orally administered is provided; the antiallergic agent comprises a hydroquinone derivative of general formula ##STR1## (wherein n represents an integer of 2-10).
5786021 Processed material of bean curd refuse and method for the preparation thereof July 28, 1998
The present invention relates to a processed material of bean curd refuse, comprising a highly viscous liquid containing cut bean curd refuse fibers and water-soluble polysaccharides released from bean curd refuse.
5416242 Hydroquinone derivative May 16, 1995
Novel hydroquinone derivatives of the formulae (I) and (II), ##STR1## wherein R.sup.1 is an alkyl group having 7 to 11 carbon atoms, ##STR2## wherein each of R.sup.2 to R.sup.5 is independently a hydrogen atom, a lower alkyl group or a lower alkoxy group provided that at least on
5276058 3,4-dihydroxychalcone derivatives January 4, 1994
Novel 3,4-dihydroxychalcone derivatives useful as a pharmaceutical material, and novel anti-inflammatory preparations. The 3,4-dihydroxychalcone derivatives are compounds of the formula [I], ##STR1## wherein X is a substituted phenyl group represented, e.g., by the formula (i),
5264421 Food composition November 23, 1993
A food composition prepared from a lactic acid fermented aqueous liquorice extract which is free of the disadvantages of extremely strong sweetness which makes liquorice extracts unsuitable for maintaining and enhancing the pharmacological activities (both disease preventing and treating
5194445 Ascorbic acid derivative March 16, 1993
The preparation for preventing and curing organ dysfunctions, provided by the present invention, is a medicament having the activity to prevent and cure organ dysfunctions which active oxygen species and active organic radical species would cause, and unconventionally improved in stabili
5143648 Ascorbic acid derivative and use as antioxidant September 1, 1992
This invention relates to a novel ascorbic acid derivative having excellent antioxidant action and a process for preparing the same.Furthermore, this invention also relates to a novel antioxidant comprising the aforementioned ascorbic acid derivative or other known ascorbic acid derivati
5109025 Therapeutic agent for penal disorders April 28, 1992
2',3,4,4'-tetrahydroxychalcone and pharmacologically acceptable salts thereof are used as a therapeutic agent for treatment of renal disorders, and have activity for treatment of renal disorders and also for treatment of renal disorders accompanied by digestive disorders, and/or general
5061812 Ascorbic acid derivative October 29, 1991
This invention relates to a novel ascorbic acid derivative having excellent antioxidant action and a process for preparing the same.Furthermore, this invention also relates to a novel antioxidant comprising the aforementioned ascorbic acid derivative or other known ascorbic acid derivati
5053490 Useful substance-albumin complex October 1, 1991
A powdery complex is obtained by combining a useful substance such as vitamin E and liquid fatty oil with albumin. This powdery complex has excellent storage stability and can keep the useful substance contained therein stably for a long time.
5051406 Pharmaceutical composition using albumin as a carrier and process for producing the same September 24, 1991
The pharmaceutical composition of the present invention is a pharmaceutical composition of high drug content containing 1-200 parts by weight of a drug having a protein binding property and 100 parts by weight of albumin.This pharmaceutical composition is produced by stirring the drug and
5034543 Ascorbic acid derivative and use as antioxidants July 23, 1991
This invention relates to a novel ascorbic acid derivative having excellent antioxidant action, particularly eliminating action on superoxides and a process for preparing the same. Furthermore, this invention also relates to a novel antioxidant comprising the afore-mentioned novel ascorb
5011949 Ascorbic acid derivative April 30, 1991
This invention relates to a novel ascorbic acid derivative having excellent antioxidant action, particularly eliminating action on superoxides and a process for preparing the same.Furthermore, this invention also relates to a novel antioxidant comprising the aforementioned novel ascorbic
5006548 Acrylamidobenzoic acid derivatives and their use April 9, 1991
Compounds of the general formula: ##STR1## wherein R.sup.1 is heterocyclic group other than pyridyl and which is unsubstituted or substituted with lower alkyl or lower alkoxycarbonyl, R.sup.2 is hydrogen, halogen, or nitro, and R.sup.3 is carboxy group or its functional derivativ
5004742 Benzothiazine-1,1-dioxide derivatives April 2, 1991
The present invention relates to novel benzothiazine-1,1-dioxide derivatives. These benzothiazine-1,1-dioxide derivatives have a high hyaluronidase-inhibiting activity and accordingly can be used in drugs such as anti-inflammatory agent, anti-allergic agent and the like.
4822791 Pharmaceutical compositions of-2,2-1,1-[bis-2,2'-(3,1-benzoxazin-4-one)9 ethylenes April 18, 1989
This invention relates to pharmaceutical compositions of compounds of the general formula: ##STR1## wherein R.sup.1 is an aryl group or a substituted aryl group wherein the substituent is halogen, hydroxy, C.sub.(1-6) lower alkoxy, C.sub.(1-6) lower alkylenedioxy, halo C.sub.(1-6
4755506 Pharmaceutical compositions of [(1,3,-dioxo-1,3-propanediyl)diimino]bisbenzoic acid derivatives July 5, 1988
Compounds of the general formula: ##STR1## wherein A and B are both hydrogen, or one of A and B is a group (G) of the formula: ##STR2## and the other is a group R.sup.5 wherein R.sup.1 is an aryl group or a heterocyclic group, both of them being optionally substituted, and R
4686206 Composition for activating function of phagocytes August 11, 1987
A pharmaceutical or veterinary composition for activating the function of phygocytes comprising as an effective ingredient a certain tocopheryl glycoside. The composition is useful for treating infectious diseases and malignant tumor.
4681895 Novel guanidinomethylcyclohexanecarboxylic acid compounds and anti-ulcer drug containing the sam July 21, 1987
Novel N-phenyl-trans-4-guanidinomethylcyclohexanecarboxamide compounds of the formula: ##STR1## wherein R is hydrogen atom or a lower alkyl group, or a pharmaceutically acceptable salt thereof, which have excellent anti-ulcer activities and hence are useful as an anti-ulcer drug,
4634777 [(1,3-dioxo-1,3-propanediyl)diimino)]bisbenzoic acid derivatives January 6, 1987
Compounds of the general formula: ##STR1## wherein A and B are both hydrogen, or one of A and B is a group (G) of the formula: ##STR2## and the other is a group R.sup.5 wherein R.sup.1 is an aryl group or a heterocyclic group, both of them being optionally substituted, and R
4617292 Pharmaceutical compositions and method for inhibiting histamine release tocopheryl glycoside October 14, 1986
A pharmaceutical composition for producing antiallergic activity containing as an active ingredient a certain tocopherol derivative having a sugar residue at 6-position of the 3,4-dihydrobenzopyrane ring thereof. A method for producing antiallergic activity using such a tocopherol deriva
4465851 Guanidinocyclohexanecarboxylic acid derivatives August 14, 1984
A compound having the formula ##STR1## wherein R.sub.1 represents an indanyl, indolyl, quinolyl or chromonyl group, the group of the formula ##STR2## (in which R.sub.2 represents a halogen atom or a nitro group), or the group of the formula ##STR3## (in which R.sub.3
4433152 Amidinopiperidine derivatives February 21, 1984
A compound of the formula, ##STR1## wherein R represents a hydrogen atom, a naphthyl, indanyl, tetrahydronaphthyl or pyridyl group, or a phenyl group which may have 1 to 3 substituents selected from the group consisting of a halogen atom, and an alkyl, alkenyl, alkoxy, alkanoyl,
4348410 Cyclohexane carboxylic acid derivatives September 7, 1982
A compound of the formula: ##STR1## wherein R.sub.1 represents a vanilyl, napthyl, pyridyl or .alpha.-tocopheryl group, or a group of the formula, ##STR2## wherein R.sub.2 represents a hydrogen atom, a lower alkoxy, formyl, lower alkanoyl or phenyl group, or a group of the fo


 
 
  Recently Added Patents
Sampling mixer with asynchronous clock and signal domains
Pneumatic spanner
Method for scattered radiation correction of a CT system having at least two focus/detector systems arranged with an angular offset, and a CT system
Light decoration
Connector with high torsion support and coaxial connector assembly thereof
Network relaying method and device
Islands-in-sea type composite fiber and process for producing the same
  Randomly Featured Patents
Liquid crystal compounds and liquid crystal display devices
High contrast photographic materials
Mappings between codewords of two distinct (N,K) Reed-Solomon codes over GF (2J)
Pop can storage device
Method of making a gastight multiple-walled plastic panel
Securing heat sinks
Process for cephalosporanic acid derivatives and intermediate therefor
Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies
Phosphatide separation
Light emitting alarm board